Susquehanna International Group, LLP Biom X Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.61 $2,836 - $6,653	10,908 New	10,908 $3,000
Q1 2023 May 16, 2023	BUY	$0.18 - $0.57 $27,754 - $87,887	154,189 Added 372.36%	195,598 $58,000
Q4 2022 Feb 14, 2023	BUY	$0.14 - $4.52 $5,797 - $187,168	41,409 New	41,409 $7,000
Q1 2022 May 16, 2022	SELL	$12.1 - $20.6 $188,191 - $320,391	-15,553 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.4 - $30.4 $24,854 - $52,470	1,726 Added 12.48%	15,553 $25,000
Q3 2021 Nov 15, 2021	BUY	$30.6 - $58.1 $423,106 - $803,348	13,827 New	13,827 $42,000

23.2M

4.33M

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $31.8M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.